Multihance at 3 Tesla (3T) in Brain Tumors

PHASE4CompletedINTERVENTIONAL
Enrollment

46

Participants

Timeline

Start Date

November 30, 2006

Primary Completion Date

February 29, 2008

Study Completion Date

March 31, 2008

Conditions
Brain Tumor
Interventions
DRUG

Multihance

0.5 M at a single injection

DRUG

Arm 2 - Magnevist

0.5 M Magnevist at a single dose injection

Trial Locations (1)

08540

Bracco Diagnostics, Inc., Princeton

Sponsors
All Listed Sponsors
lead

Bracco Diagnostics, Inc

INDUSTRY